The retinoblastoma tumor suppressor gene RB1 is more commonly mutated in metastatic and ADT-recurrent prostate cancer than in primary tumors, while the expression of the ST6GalNAc1 gene is upregulated in primary prostate cancer cells and repressed in patients undergoing androgen deprivation therapy [4]. Here, ST6GALNAC1 is linked to prostate cancer.